# Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

> **NCT00189202** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Michigan** · enrollment: 49 (actual)

## Conditions studied

- End Stage Renal Disease
- Kidney Transplantation

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00189202
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2008-07-01
- **Final completion:** 2008-07-01
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2018-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189202, "Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00189202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*